Transfection of Noggin in bone marrow stromal cells (BMSCs) enhances BMSC-induced functional outcome after stroke in rats

Journal of Neuroscience Research

Volumn 89, Issue 8, 2011, Pages 1194-1202

  Chen, Chen ^a   Cheng, Yan ^a   Chen, Jieli ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b HENRY FORD HOSPITAL   (United States)

Author keywords

Bone marrow stromal cell; Neurogenesis; Neuroprotection; Noggin; Stroke

Indexed keywords

ADENOVIRUS VECTOR; GREEN FLUORESCENT PROTEIN; NOGGIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW; BRAIN ISCHEMIA; CELL PROLIFERATION; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVOUS SYSTEM DEVELOPMENT; NEUROPROTECTION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; STROKE; STROMA CELL;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; BRAIN ISCHEMIA; CARRIER PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; STROKE; STROMAL CELLS; TRANSFECTION; TREATMENT OUTCOME;

EID: 79957812970     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22662     Document Type: Article

References (31)

1. Bonaguidi MA, Peng CY, McGuire T, Falciglia G, Gobeske KT, Czeisler C, Kessler JA. 2008. Noggin expands neural stem cells in the adult hippocampus. J Neurosci 28: 9194-9204.
2. Chen J, Li Y, Wang L, Lu M, Zhang X, Chopp M. 2001. Therapeutic benefit of intracerebral transplantation of bone marrow stromal cells after cerebral ischemia in rats. J Neurol Sci 189: 49-57.
3. Chen J, Li Y, Katakowski M, Chen X, Wang L, Lu D, Lu M, Gautam SC, Chopp M. 2003a. Intravenous bone marrow stromal cell therapy reduces apoptosis and promotes endogenous cell proliferation after stroke in female rat. J Neurosci Res 73: 778-786.
4. Chen J, Zhang ZG, Li Y, Wang L, Xu YX, Gautam SC, Lu M, Zhu Z, Chopp M. 2003b. Intravenous administration of human bone marrow stromal cells induces angiogenesis in the ischemic boundary zone after stroke in rats. Circ Res 92: 692-699.
5. Chen X, Li Y, Wang L, Katakowski M, Zhang L, Chen J, Xu Y, Gautam SC, Chopp M. 2002. Ischemic rat brain extracts induce human marrow stromal cell growth factor production. Neuropathology 22: 275-279.
6. Chopp M, Li Y. 2002. Treatment of neural injury with marrow stromal cells. Lancet Neurol 1: 92-100.
7. Ding J, Cheng Y, Gao S, Chen J. 2011. Effects of nerve growth factor and Noggin-modified bone marrow stromal cells on stroke in rats. J Neurosci Res 89: 222-230.
8. Engelhorn T, von Kummer R, Reith W, Forsting M, Doerfler A. 2002. What is effective in malignant middle cerebral artery infarction: reperfusion, craniectomy, or both? An experimental study in rats. Stroke 33: 617-622.
9. Hamano K, Li TS, Kobayashi T, Kobayashi S, Matsuzaki M, Esato K. 2000. Angiogenesis induced by the implantation of self-bone marrow cells: a new material for therapeutic angiogenesis. Cell Transplant 9: 439-443.
10. Honma T, Honmou O, Iihoshi S, Harada K, Houkin K, Hamada H, Kocsis JD. 2006. Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Exp Neurol 199: 56-66.
11. Horita Y, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD. 2006. Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat. J Neurosci Res 84: 1495-1504.
12. Huang ZG, Xue D, Preston E, Karbalai H, Buchan AM. 1999. Biphasic opening of the blood-brain barrier following transient focal ischemia: effects of hypothermia. Can J Neurol Sci 26: 298-304.
13. Iihoshi S, Honmou O, Houkin K, Hashi K, Kocsis JD. 2004. A therapeutic window for intravenous administration of autologous bone marrow after cerebral ischemia in adult rats. Brain Res 1007: 1-9.
14. Johansson BB, Ohlsson AL. 1996. Environment, social interaction, and physical activity as determinants of functional outcome after cerebral infarction in the rat. Exp Neurol 139: 322-327.
15. Kempermann G, Wiskott L, Gage FH. 2004. Functional significance of adult neurogenesis. Curr Opin Neurobiol 14: 186-191.
16. Komotar RJ, Kim GH, Sughrue ME, Otten ML, Rynkowski MA, Kellner CP, Hahn DK, Merkow MB, Garrett MC, Starke RM, Connolly ES. 2007. Neurologic assessment of somatosensory dysfunction following an experimental rodent model of cerebral ischemia. Nat Protoc 2: 2345-2347.
17. Kurozumi K, Nakamura K, Tamiya T, Kawano Y, Kobune M, Hirai S, Uchida H, Sasaki K, Ito Y, Kato K, Honmou O, Houkin K, Date I, Hamada H. 2004. BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model. Mol Ther 9: 189-197.
18. Li Y, Chen J, Chen XG, Wang L, Gautam SC, Xu YX, Katakowski M, Zhang LJ, Lu M, Janakiraman N, Chopp M. 2002. Human marrow stromal cell therapy for stroke in rat: neurotrophins and functional recovery. Neurology 59: 514-523.
19. Lim DA, Tramontin AD, Trevejo JM, Herrera DG, Garcia-Verdugo JM, Alvarez-Buylla A. 2000. Noggin antagonizes BMP signaling to create a niche for adult neurogenesis. Neuron 28: 713-726.
20. Liu F, Schafer DP, McCullough LD. 2009. TTC, Fluoro-Jade B and NeuN staining confirm evolving phases of infarction induced by middle cerebral artery occlusion. J Neurosc Methods 179: 1-8.
21. Liu H, Honmou O, Harada K, Nakamura K, Houkin K, Hamada H, Kocsis JD. 2006. Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia. Brain 129: 2734-2745.
22. Nakatomi H, Kuriu T, Okabe S, Yamamoto S, Hatano O, Kawahara N, Tamura A, Kirino T, Nakafuku M. 2002. Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 110: 429-441.
23. Neumann-Haefelin T, Kastrup A, de Crespigny A, Yenari MA, Ringer T, Sun GH, Moseley ME. 2000. Serial MRI after transient focal cerebral ischemia in rats: dynamics of tissue injury, blood-brain barrier damage, and edema formation. Stroke 31: 1965-1972; discussion 1972-1963.
24. Nomura T, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD. 2005. I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat. Neuroscience 136: 161-169.
25. Onda T, Honmou O, Harada K, Houkin K, Hamada H, Kocsis JD. 2008. Therapeutic benefits by human mesenchymal stem cells (hMSCs) and Ang-1 gene-modified hMSCs after cerebral ischemia. J Cereb Blood Flow Metab 28: 329-340.
26. Samanta J, Alden T, Gobeske K, Kan L, Kessler JA. 2010. Noggin protects against ischemic brain injury in rodents. Stroke 41: 357-362.
27. Seo MS, Jeong YH, Park JR, Park SB, Rho KH, Kim HS, Yu KR, Lee SH, Jung JW, Lee YS, Kang KS. 2009. Isolation and characterization of canine umbilical cord blood-derived mesenchymal stem cells. J Vet Sci 10: 181-187.
28. Takahashi K, Ito Y, Morikawa M, Kobune M, Huang J, Tsukamoto M, Sasaki K, Nakamura K, Dehari H, Ikeda K, Uchida H, Hirai S, Abe T, Hamada H. 2003. Adenoviral-delivered angiopoietin-1 reduces the infarction and attenuates the progression of cardiac dysfunction in the rat model of acute myocardial infarction. Mol Ther 8: 584-592.
29. Valenzuela DM, Economides AN, Rojas E, Lamb TM, Nunez L, Jones P, Lp NY, Espinosa R3rd, Brannan CI, Gilbert DJ, et al. 1995. Identification of mammalian noggin and its expression in the adult nervous system. J Neurosci 15: 6077-6084.
30. Zhang RL, Zhang ZG, Zhang L, Chopp M. 2001. Proliferation and differentiation of progenitor cells in the cortex and the subventricular zone in the adult rat after focal cerebral ischemia. Neuroscience 105: 33-41.
31. Zimmerman LB, De Jesus-Escobar JM, Harland RM. 1996. The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86: 599-606.